The DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.
Specific chemotherapy of Chagas disease: controversies and advances
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Therapeutic Approaches to Bone Diseases
Rodan, G. A., & Martin, T. J. (2000) · Science · doi:10.1126/science.289.5484.1508 · Cited by 1,767
A Critical Review on Chagas Disease Chemotherapy
Coura, J. R., & Castro, S. L. D. (2002) · Memórias do Instituto Oswaldo Cruz · doi:10.1590/s0074-02762002000100001 · Cited by 1,003
Cysteine Protease Inhibitors Cure an Experimental Trypanosoma cruzi Infection
Engel, J. C., Doyle, P. S., Hsieh, I., & McKerrow, J. H. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.188.4.725 · Cited by 392
Du, X., Guo, C., Hansell, E., Doyle, P. S., Caffrey, C. R., Holler, T. P., McKerrow, J. H., & Cohen, F. E. (2002) · Journal of Medicinal Chemistry · doi:10.1021/jm010459j · Cited by 381
Immnunological Control of Trypanosoma cruzi Infection and Pathogenesis of Chagas’ Disease
Brener, Z., & Gazzinelli, R. T. (2009) · International Archives of Allergy and Immunology · doi:10.1159/000237653 · Cited by 376
Cazzulo, J. J., Stoka, V., & Türk, V. (2001) · Current Pharmaceutical Design · doi:10.2174/1381612013397528 · Cited by 174
Urbina, J. A., Payares, G., Sanoja, C., Lira, R., & Romanha, A. J. (2003) · International Journal of Antimicrobial Agents · doi:10.1016/s0924-8579(02)00273-x · Cited by 167
Self-citationBisphosphonates Are Potent Inhibitors of Trypanosoma cruzi Farnesyl Pyrophosphate Synthase
Montalvetti, A., Bailey, B. N., Martin, M., Severin, G. W., Oldfield, E., & Docampo, R. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m103950200 · Cited by 151
Self-citationDocampo, R. (2001) · Molecular and Biochemical Parasitology · doi:10.1016/s0166-6851(01)00246-8 · Cited by 138
Self-citation
Cited by
The Genome of the African Trypanosome Trypanosoma brucei
Berriman, M., Ghedin, E., Hertz-Fowler, C., Blandin, G., Renauld, H., Bartholomeu, D. C., Lennard, N. J., Caler, E., Hamlin, N. E., Haas, B., et al. (2005) · Science · doi:10.1126/science.1112642 · Cited by 1,631
Opportunities and Challenges in Antiparasitic Drug Discovery
Pink, R., Hudson, A., Mouriès, M.-A., & Bendig, M. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1824 · Cited by 545
Specific chemotherapy of Chagas disease: Relevance, current limitations and new approaches
Urbina, J. A. (2010) · Acta Tropica · doi:10.1016/j.actatropica.2009.10.023 · Cited by 473
Self-citationAcidocalcisomes ? conserved from bacteria to man
Docampo, R., de Souza, W., Miranda, K., Rohloff, P., & Moreno, S. N. J. (2005) · Nature Reviews Microbiology · doi:10.1038/nrmicro1097 · Cited by 468
Self-citationPharmaceutically active secondary metabolites of marine actinobacteria
Manivasagan, P., Venkatesan, J., Sivakumar, K., & Kim, S.-K. (2014) · Microbiological Research · doi:10.1016/j.micres.2013.07.014 · Cited by 416
Drug repurposing and human parasitic protozoan diseases
Andrews, K. T., Fisher, G., & Skinner-Adams, T. S. (2014) · International Journal for Parasitology: Drugs and Drug Resistance · doi:10.1016/j.ijpddr.2014.02.002 · Cited by 383
Experimental and Clinical Treatment of Chagas Disease: A Review
Sales Junior, P. A., Molina, I., Fonseca Murta, S. M., Sánchez-Montalvá, A., Salvador, F., Corrêa-Oliveira, R., & Carneiro, C. M. (2017) · The American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.16-0761 · Cited by 305
Parasitic diseases: Liposomes and polymeric nanoparticles versus lipid nanoparticles☆
DATE, A., JOSHI, M., & PATRAVALE, V (2007) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.04.009 · Cited by 293
Duffy, T., Cura, C. I., Ramirez, J. C., Abate, T., Cayo, N. M., Parrado, R., Bello, Z. D., Velazquez, E., Muñoz-Calderon, A., Juiz, N. A., et al. (2013) · PLoS Neglected Tropical Diseases · doi:10.1371/journal.pntd.0002000 · Cited by 257
Demeu, L. M. K., Soares, R. J., Miranda, J. S., Pacheco-Lugo, L. A., Oliveira, K. G., Cortez Plaza, C. A., Billiald, P., Ferreira de Moura, J., Yoshida, N., Alvarenga, L. M., et al. (2019) · PLOS ONE · doi:10.1371/journal.pone.0223773 · Cited by 7
Metadata
- Authors
- Urbina, J. A., & Docampo, R.
- Venue
- Trends in Parasitology
- Publisher
- Elsevier BV
- Published
- 2003-11
- Volume
- 19
- Issue
- 11
- Pages
- 495-501
- ISSN
- 1471-4922 (ISSN-L)
- OpenAlex
- W2021217831
- Cited by
- 567
- References
- 18
- FWCI
- 3.61
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.